Common Interactions between S100A4 and S100A9 Defined by a Novel Chemical Probe

Induction of nuclear factor-κB responses by the S100A9 protein is Toll-like receptor-4-dependent

(2012) Matteo Riva et al.   IMMUNOLOGY

S100A9 Interaction with TLR4 Promotes Tumor Growth

(2012) Eva Källberg et al.   PLoS One

Inhibition of metastasis in a castration resistant prostate cancer model by the quinoline-3-carboxamide tasquinimod (ABR-215050)

(2011) Karin Jennbacken et al.   PROSTATE

Antineoplastic Mechanisms of Niclosamide in Acute Myelogenous Leukemia Stem Cells: Inactivation of the NF- B Pathway and Generation of Reactive Oxygen Species

(2010) Y. Jin et al.   CANCER RESEARCH

Nuclear S100A4 is a novel prognostic marker in colorectal cancer

(2010) Kjetil Boye et al.   EUROPEAN JOURNAL OF CANCER

Sumoylation and Nuclear Translocation of S100A4 Regulate IL-1β-mediated Production of Matrix Metalloproteinase-13

(2010) Keally J. Miranda et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

Tasquinimod (ABR-215050), a quinoline-3-carboxamide anti-angiogenic agent, modulates the expression of thrombospondin-1 in human prostate tumors

(2010) Anders Olsson et al.   Molecular Cancer

S100A4 mediates endometrial cancer invasion and is a target of TGF-β1 signaling

(2009) Ran Xie et al.   LABORATORY INVESTIGATION

Different Expression and Clinical Role of S100A4 in Serous Ovarian Carcinoma at Different Anatomic Sites

(2009) Gunhild M. Mælandsmo et al.   TUMOR BIOLOGY

Identification of Human S100A9 as a Novel Target for Treatment of Autoimmune Disease via Binding to Quinoline-3-Carboxamides

(2009) Per Björk et al.   PLOS BIOLOGY

RAGE signaling sustains inflammation and promotes tumor development

(2008) Christoffer Gebhardt et al.   JOURNAL OF EXPERIMENTAL MEDICINE

Inhibition of dendritic cell differentiation and accumulation of myeloid-derived suppressor cells in cancer is regulated by S100A9 protein

(2008) Pingyan Cheng et al.   JOURNAL OF EXPERIMENTAL MEDICINE